Site Search

Purpose Phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha ( PIK3CA) mutations are frequently observed in primary breast cancer. We evaluated their prognostic relevance by performing a pooled analysi...
Cyclin-dependent kinase (CDK4/6) inhibitors in combination with endocrine therapy are currently the optimal first line treatment for hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) non-amp...
Resistance to endocrine therapy is a significant therapeutic challenge in the treatment of women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer. Cyc...
OBJECTIVE: The purpose of this article is to describe the large number of radiotracers being evaluated for prostate-specific membrane antigen (PSMA) PET, which is becoming a central tool in the staging of prostate cancer...
To formulate clinical consensus recommendations on bone health assessment and management of women with oestrogen receptor-positive early breast cancer receiving endocrine therapy, representatives appointed by relevant Au...

The 2019 Garvan Researcher Awards

Jun 12, 2019 02:57 PM
Congratulations to the seven researchers who were presented with awards or prizes at the 2019 Garvan Researcher Awards event.

Terms and Conditions

Dec 07, 2018 01:31 PM

A genomic barcode tracker for immune cells

MEDIA RELEASE: Jul 17, 2019 08:22 AM
A new research method to pinpoint the immune cells that recognise cancer could significantly change how we treat the disease.

20 January 2020

Aug 06, 2019 04:02 PM

26 February 2020

Aug 06, 2019 04:02 PM

Making genomics teachable

Apr 01, 2019 04:30 PM
A Garvan-Weizmann collaboration is upskilling science teachers to educate students about genomics.
Nicotinamide adenine dinucleotide (NAD(+)) is modulated by conditions of metabolic stress and has been reported to decline with aging in preclinical models, but human data are sparse. Nicotinamide riboside (NR) supplemen...

Thank you for subscribing

Nov 27, 2018 12:14 PM
Medical researcher, mountain runner, single-cell pioneer, father: Associate Professor Joseph Powell wears many hats. Now, he has joined Garvan as the Head of the Garvan-Weizmann Centre of Cellular Genomics, and as head o...

Our obesity research

Dec 18, 2017 02:30 PM